Vapotherm (NYSE:VAPO) Shares Up 0.6%

Vapotherm, Inc. (NYSE:VAPOGet Free Report) shot up 0.6% during mid-day trading on Wednesday . The company traded as high as $1.40 and last traded at $1.33. 20,470 shares traded hands during mid-day trading, an increase of 90% from the average session volume of 10,784 shares. The stock had previously closed at $1.32.

Vapotherm Stock Performance

The business’s fifty day moving average is $1.07 and its 200-day moving average is $1.79. The firm has a market cap of $8.25 million, a P/E ratio of -0.13 and a beta of -1.15.

Vapotherm (NYSE:VAPOGet Free Report) last issued its quarterly earnings data on Thursday, February 22nd. The company reported ($1.60) earnings per share (EPS) for the quarter. The company had revenue of $19.73 million for the quarter.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. acquired a new stake in shares of Vapotherm during the 4th quarter worth approximately $28,000. Engineers Gate Manager LP purchased a new position in Vapotherm during the 4th quarter worth $34,000. Virtu Financial LLC purchased a new position in Vapotherm during the 4th quarter worth $53,000. Jane Street Group LLC bought a new stake in shares of Vapotherm during the 2nd quarter worth $58,000. Finally, Price T Rowe Associates Inc. MD raised its stake in shares of Vapotherm by 46.3% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 22,750 shares of the company’s stock worth $58,000 after purchasing an additional 7,205 shares during the period. Institutional investors own 43.08% of the company’s stock.

Vapotherm Company Profile

(Get Free Report)

Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface.

Further Reading

Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.